Ritonavir - Latest Advances

SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots.

Journal: Emerging microbes & infections

Published: October 15, 2025

Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters.

Journal: Nano research

Published: September 29, 2025

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.

Journal: Antimicrobial agents and chemotherapy

Published: September 26, 2025

Predicting Drug-Drug Interaction via Dual-Drug Visual Representation.

Journal: Journal of chemical information and modeling

Published: September 26, 2025

Mixed methods implementation research of oral antiviral treatment for COVID-19 in low- and middle-income countries: a study protocol.

Journal: BMJ open

Published: September 19, 2025

Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral Activity.

Journal: Journal of medicinal chemistry

Published: September 11, 2025

Comparison of In Vitro and In Vivo Dissolution of Norvir® Oral Powder: In Vivo Relevance of a too Rapid In Vitro Dissolution Test.

Journal: Turkish journal of pharmaceutical sciences

Published: September 08, 2025

Inequities in COVID-19 antiviral dispensation in Victoria, Australia: A retrospective cohort study using linked data.

Journal: Australian journal of general practice

Published: September 05, 2025

Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.

Journal: Infectious diseases (London, England)

Published: September 05, 2025

A Super-Resolution Spatial Atlas of SARS-CoV-2 Infection in Human Cells.

Journal: bioRxiv : the preprint server for biology

Published: September 02, 2025

Beyond ritonavir-boosted nirmatrelvir: the case for ensitrelvir in COVID-19 treatment.

Journal: The Lancet. Infectious diseases

Published: September 02, 2025

Immune reconstitution in very advanced HIV patients treated with Dolutegravir vs Darunavir-based triple antiretroviral therapy. The Advanz-4 randomized clinical trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 16, 2025

Filters

SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots.

SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots.

Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters.

Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters.

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.

Predicting Drug-Drug Interaction via Dual-Drug Visual Representation.

Predicting Drug-Drug Interaction via Dual-Drug Visual Representation.

Mixed methods implementation research of oral antiviral treatment for COVID-19 in low- and middle-income countries: a study protocol.

Mixed methods implementation research of oral antiviral treatment for COVID-19 in low- and middle-income countries: a study protocol.

Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral Activity.

Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral Activity.

Comparison of In Vitro and In Vivo Dissolution of Norvir® Oral Powder: In Vivo Relevance of a too Rapid In Vitro Dissolution Test.

Comparison of In Vitro and In Vivo Dissolution of Norvir® Oral Powder: In Vivo Relevance of a too Rapid In Vitro Dissolution Test.

Inequities in COVID-19 antiviral dispensation in Victoria, Australia: A retrospective cohort study using linked data.

Inequities in COVID-19 antiviral dispensation in Victoria, Australia: A retrospective cohort study using linked data.

Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.

Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.

A Super-Resolution Spatial Atlas of SARS-CoV-2 Infection in Human Cells.

A Super-Resolution Spatial Atlas of SARS-CoV-2 Infection in Human Cells.

Beyond ritonavir-boosted nirmatrelvir: the case for ensitrelvir in COVID-19 treatment.

Beyond ritonavir-boosted nirmatrelvir: the case for ensitrelvir in COVID-19 treatment.

Immune reconstitution in very advanced HIV patients treated with Dolutegravir vs Darunavir-based triple antiretroviral therapy. The Advanz-4 randomized clinical trial.

Immune reconstitution in very advanced HIV patients treated with Dolutegravir vs Darunavir-based triple antiretroviral therapy. The Advanz-4 randomized clinical trial.